Most recent news and milestone just acheived13 Jun 2025 11:22
Ananda Pharma has successfully completed stability testing for its lead cannabidiol (CBD) drug candidate, MRX1, achieving two years of stability data under internationally recognized pharmaceutical standards. This data confirms the drug's formulation maintains its quality, safety, and efficacy over time. The stability testing was conducted according to ICH